Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GTX + Cisplatin in Metastatic Pancreatic Cancer
NCT01459614Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Nov 2011
- Primary completion
- Nov 2016
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Nov 2011; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)
Beyond the preview
Go deeper on NCT01459614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01459614.